Reproductive endocrinology and fertility face a prior-authorization challenge that is partly about documentation and partly about structural coverage fragmentation. For patients in states without a coverage mandate — the majority of the country — the PA question is moot because there’s no coverage to authorize. For patients in mandate states or with employer plans that include coverage, prior authorization gates every treatment cycle, every injection protocol, and in many cases every frozen embryo transfer.
The financial stakes are higher than almost any other specialty: IVF costs $15,000–$25,000 per cycle out of pocket, which means a PA denial isn’t just a documentation problem — it’s a question of whether the patient can continue treatment at all.
The numbers in reproductive endocrinology
The coverage landscape as of 2025:
- 15 states mandate IVF coverage; 25 states have enacted some form of fertility insurance law — but mandate scope varies widely, from full IVF coverage to diagnostic-only requirements (RESOLVE, 2025).
- In the remaining states, fertility coverage is entirely employer-determined, and most employer plans without a state mandate exclude IVF.
- When coverage exists, each treatment cycle typically requires separate prior authorization — diagnosis documentation, prior treatment history, and payer-specific criteria for the specific intervention being requested.
These sit on the universal physician burden: 39 authorizations per week, roughly 13 hours lost to them, 82% reporting PA can lead patients to abandon treatment, and 93% reporting PA delays care (AMA 2024). In fertility medicine, “treatment abandonment” often means a patient stops pursuing biological parenthood because the coverage and authorization process made it impossible to continue.
Why reproductive endocrinology is different
- Coverage absence is the first wall. Before prior authorization even becomes relevant, the patient and practice must navigate whether the plan covers fertility treatment at all. In states without a mandate, the conversation often ends there. PA is the second wall, not the first.
- Per-cycle authorization. When IVF is covered, most payers require authorization for each cycle — not a standing authorization for a treatment course. A patient undergoing multiple IVF cycles needs multiple authorization events, each requiring documentation of the cumulative cycle count and payer-imposed cycle limits.
- Infertility diagnosis criteria. Payer definitions of “infertility” frequently require 12 months of documented unprotected intercourse without conception (6 months for patients over 35), excluding patients with documented anatomical factors, male factor infertility, or prior fertility treatment history. Assembling this documentation in payer-acceptable format is a recurring task.
- Gonadotropin PA. Injectable FSH, LH, and hCG used for ovarian stimulation typically require separate PA from the procedure itself. A patient starting an IVF cycle may need authorization for the stimulation medications, the egg retrieval, the fresh transfer, and a subsequent frozen embryo transfer — each authorized separately, each requiring its own documentation pass.
- Time sensitivity. Fertility treatment is acutely time-sensitive in ways most medical treatment isn’t: ovarian stimulation works within a cycle’s window, and a PA delay that pushes a cycle by 30 days is a 30-day delay in the patient’s biological time. For patients with diminished ovarian reserve or age-related fertility decline, cycle delays are clinically meaningful.
What it costs
The direct financial cost to patients is the clearest: without authorization, a cycle costs $15,000–$25,000 out of pocket, and many patients stop after one or two failed cycles when coverage lapses or authorizations don’t clear in time. For the practice, the operational cost is high-volume documentation management — per-cycle, per-medication, per-transfer authorizations at roughly $10.81 per manually processed authorization (CAQH 2023) — across a patient population that is already managing significant emotional and financial stress.
How to cut the wait
Fertility authorization documentation is structured clinical history: infertility diagnosis, prior treatment record, cycle count, and payer-specific criteria. Artificer Health:
- Verifies coverage and eligibility before initiating the authorization process, so the practice knows which patients have coverage and what their cycle limits are before beginning documentation work.
- Assembles the per-cycle authorization packet — diagnosis documentation, prior treatment history, clinical rationale, and the payer-specific criteria for each cycle type.
- Tracks per-medication PA for injectable stimulation agents in parallel with the procedure authorization so treatment can begin as soon as the cycle window opens.
For patients who have limited treatment windows — biological, financial, or both — a PA process that takes days instead of weeks is not a convenience. It’s part of the clinical care.
Sources: RESOLVE: The National Infertility Association, resolve.org/learn/financial-resources/insurance-coverage/insurance-coverage-by-state/ (accessed June 2026, 15 IVF mandate states / 25 with any fertility law); payer medical policies for IVF, injectable gonadotropins, and embryo cryopreservation; AMA 2024 Prior Authorization Physician Survey (n=1,000); CAQH 2023 Index.